G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

Venugopalan CheriyathErnest C Borden


Hormonally regulated survival factors can have an important role in breast cancer. Here we elucidate G1P3, a survival protein induced by interferons (IFNs), as a target of estrogen signaling and a contributor to poor outcomes in estrogen receptor-positive (ER(+)) breast cancer. Compared with normal breast tissue, G1P3 was upregulated in the malignant epithelium (50 × higher) and was induced by estrogen ex vivo. In accord with its overexpression in early stages of breast cancer (hyperplasia and ductal carcinoma in situ), in morphogenesis assays G1P3 enhanced the survival of MCF10A acinar luminal cells causing hyperplasia by suppressing detachment-induced loss of mitochondrial potential and apoptosis (anoikis). In cells undergoing anoikis, G1P3 attenuated the induction of Bim protein, a proapoptotic member of the Bcl-2 family and reversed the downmodulation of Bcl-2 protein. Downregulation of G1P3 induced spontaneous apoptosis in BT-549 breast cancer cells and significantly reduced the growth of ER(+) breast cancer cell MCF7 (P≤0.01), further suggesting its prosurvival activity. In agreement with its induction by estrogen, G1P3 antagonized tamoxifen, an inhibitor of ER in MCF7 cells. More importantly, elevated expression of G1P3 ...Continue Reading


Sep 5, 2001·Nature Cell Biology·Senthil K MuthuswamyJoan S Brugge
Jun 12, 2003·Methods : a Companion to Methods in Enzymology·Jayanta DebnathJoan S Brugge
Jul 5, 2003·Nature Cell Biology·Mauricio J ReginatoJoan S Brugge
Apr 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Christopher HaqqMohammed Kashani-Sabet
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Davendra SegaraSusan M Henshall
Nov 25, 2005·British Journal of Cancer·A PuisieuxS Ansieau
Jan 7, 2006·Nature Reviews. Cancer·Karin E de VisserLisa M Coussens
Feb 16, 2006·Journal of the National Cancer Institute·Christos SotiriouMauro Delorenzi
Mar 17, 2006·Cancer Research·Melanie Braig, Clemens A Schmitt
May 2, 2006·Cancer Letters·Hellinida ThomadakiAndreas Scorilas
Aug 31, 2006·Methods in Enzymology·Alexander I SaeedJohn Quackenbush
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xiao-Jun MaMark G Erlander
Oct 26, 2006·Nature Reviews. Immunology·Gavin P DunnRobert D Schreiber
Mar 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elisa WurmbachJosep M Llovet
Apr 5, 2007·Nature Protocols·Nicolaas A P FrankenChris van Bree
Apr 21, 2007·Reviews in Endocrine & Metabolic Disorders·Evette S Radisky, Derek C Radisky
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christine DesmedtTRANSBIG Consortium
Aug 21, 2007·Breast Cancer Research : BCR·Raffaele Adolfo CalogeroFederica Cavallo
Sep 8, 2007·The Journal of Clinical Investigation·Venugopalan CheriyathErnest C Borden
Sep 26, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Craig Jordan, Bert W O'Malley
Nov 28, 2007·Annual Review of Pathology·Christy HebnerJayanta Debnath
Dec 1, 2007·Nature Reviews. Drug Discovery·Ernest C BordenGeorge R Stark
Dec 11, 2007·Cancer Metastasis Reviews·David G DeNardoLisa M Coussens
Feb 8, 2008·BMC Genomics·Hui YeXiaofeng Zhou
Mar 13, 2008·Médecine sciences : M/S·Arnaud A MailleuxJoan S Brugge
May 6, 2008·Seminars in Cancer Biology·Britta Weigelt, Mina J Bissell
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Nov 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ralph R WeichselbaumAndy J Minn
Mar 7, 2009·Breast Cancer Research and Treatment·Dung-Tsa ChenTimothy Yeatman
May 16, 2009·Current Cancer Drug Targets·Pepita Giménez-BonaféRicardo Pérez-Tomás
May 14, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P ErolesA Lluch
Oct 14, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Venugopalan CheriyathErnest C Borden


Nov 26, 2013·International Journal of Molecular Medicine·Marjaneh MotaghedShahrul Sahul Hamid
Apr 5, 2016·Nutrition and Cancer·Kailee A JohnsonVenugopalan Cheriyath
Feb 6, 2017·Proceedings of the National Academy of Sciences of the United States of America·Hangfei QiRen Sun
Aug 8, 2020·Molecular Biology Reports·Jie JiMing-Bing Xiao
Sep 26, 2015·Oncotarget·Ronit Vogt SionovZvi Granot
Jan 27, 2019·Nature Reviews. Drug Discovery·Ernest C Borden
Jan 25, 2020·American Journal of Clinical Pathology·Hao LiZhi-Jun Sun
Apr 17, 2020·Frontiers in Immunology·Laura Martin-Hijano, Bruno Sainz
May 23, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nikolai N KhodarevRalph R Weichselbaum
Apr 18, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Annemarie E M PostPaul N Span
Jan 15, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Shinji KohsakaHiroyuki Mano
Mar 10, 2019·The Journal of Steroid Biochemistry and Molecular Biology·Priya BhardwajKristy A Brown
Mar 9, 2021·Immunology·Mario Riera-Romo

Related Concepts

BCL2L11 protein, human
IFI6 protein, human
BCL2-Related Protein 11
Mammary Neoplasms, Human
Cell Surface Proteins
Neoplasms, Hormone-Dependent
Proto-Oncogene Proteins
Estrogen Nuclear Receptor

Related Feeds


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.